Global Type 1 Diabetes (T1D) Market Research Report 2022(Status and Outlook)

June 2022 | 114 pages | ID: G8F6D737F051EN
Bosson Research

Abstracts

Report Overview

Type 1 diabetes (T1D) is an autoimmune disease that occurs when a person’s pancreas stops producing insulin, the hormone that controls blood-sugar levels. T1D develops when the insulin-producing pancreatic beta cells are mistakenly destroyed by the body’s immune system. The cause of this attack is still being researched, however scientists believe the cause may have genetic and environmental components.

Sedentary lifestyle, unhealthy diet, lack of exercise and increasing prevalence of diabetes are key driver for Type 1 Diabetes (T1D) market. Insulin therapy is very much essential in the patients who have type 1 diabetes. Rising launch of the novel insulin formulations along with several adjunct therapies will positively impact the insulin acceptance. On the other hand, this chronic disorder poses a significant economic impact owing to the increasing cost of insulin coupled with other conditions such as cardiac disorders, kidney disease among others. While insulin therapy keeps people with T1D alive and can help keep blood-glucose levels within recommended range, it is not a cure, nor does it prevent the possibility of T1D’s serious effects. Although T1D is a serious and challenging disease, long-term management options continue to evolve, allowing those with T1D to have full and active lives. Asia Pacific region recorded the highest growth rate over the forecast period owing to the increasingly sedentary lifestyles, obese population, and improper food habits. North America accounted for more than 5% of the total market share over the forecast period.

The Global Type 1 Diabetes (T1D) Market Size was estimated at USD 1903.29 million in 2021 and is projected to reach USD 2615.55 million by 2028, exhibiting a CAGR of 4.65% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Type 1 Diabetes (T1D) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Type 1 Diabetes (T1D) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Type 1 Diabetes (T1D) market in any manner.

Global Type 1 Diabetes (T1D) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

• Novo Nordisk
• Sanofi
• Eli Lilly
• Merck
• Boehringer Ingelheim
• Samsung Bioepis
• Biocon
• Astellas
• Janssen
• Bristol-Myers Squibb
• Lexicon
• Sanofi

Market Segmentation (by Type)

• Rapid Acting Insulin Analogs
• Long Acting Insulin Analogs
• Premix Insulin Analogs

Market Segmentation (by Application)

• Children
• Adults

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Type 1 Diabetes (T1D) Market
• Overview of the regional outlook of the Type 1 Diabetes (T1D) Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Type 1 Diabetes (T1D) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Type 1 Diabetes (T1D)
1.2 Key Market Segments
  1.2.1 Type 1 Diabetes (T1D) Segment by Type
  1.2.2 Type 1 Diabetes (T1D) Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 TYPE 1 DIABETES (T1D) MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Type 1 Diabetes (T1D) Market Size (M USD) Estimates and Forecasts (2017-2028)
  2.1.2 Global Type 1 Diabetes (T1D) Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 TYPE 1 DIABETES (T1D) MARKET COMPETITIVE LANDSCAPE

3.1 Global Type 1 Diabetes (T1D) Sales by Manufacturers (2017-2022)
3.2 Global Type 1 Diabetes (T1D) Revenue Market Share by Manufacturers (2017-2022)
3.3 Type 1 Diabetes (T1D) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Type 1 Diabetes (T1D) Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Type 1 Diabetes (T1D) Sales Sites, Area Served, Product Type
3.6 Type 1 Diabetes (T1D) Market Competitive Situation and Trends
  3.6.1 Type 1 Diabetes (T1D) Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Type 1 Diabetes (T1D) Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 TYPE 1 DIABETES (T1D) INDUSTRY CHAIN ANALYSIS

4.1 Type 1 Diabetes (T1D) Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF TYPE 1 DIABETES (T1D) MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 TYPE 1 DIABETES (T1D) MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Type 1 Diabetes (T1D) Sales Market Share by Type (2017-2022)
6.3 Global Type 1 Diabetes (T1D) Market Size Market Share by Type (2017-2022)
6.4 Global Type 1 Diabetes (T1D) Price by Type (2017-2022)

7 TYPE 1 DIABETES (T1D) MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Type 1 Diabetes (T1D) Market Sales by Application (2017-2022)
7.3 Global Type 1 Diabetes (T1D) Market Size (M USD) by Application (2017-2022)
7.4 Global Type 1 Diabetes (T1D) Sales Growth Rate by Application (2017-2022)

8 TYPE 1 DIABETES (T1D) MARKET SEGMENTATION BY REGION

8.1 Global Type 1 Diabetes (T1D) Sales by Region
  8.1.1 Global Type 1 Diabetes (T1D) Sales by Region
  8.1.2 Global Type 1 Diabetes (T1D) Sales Market Share by Region
8.2 North America
  8.2.1 North America Type 1 Diabetes (T1D) Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Type 1 Diabetes (T1D) Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Type 1 Diabetes (T1D) Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Type 1 Diabetes (T1D) Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Type 1 Diabetes (T1D) Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILED

9.1 Novo Nordisk
  9.1.1 Novo Nordisk Type 1 Diabetes (T1D) Basic Information
  9.1.2 Novo Nordisk Type 1 Diabetes (T1D) Product Overview
  9.1.3 Novo Nordisk Type 1 Diabetes (T1D) Product Market Performance
  9.1.4 Novo Nordisk Business Overview
  9.1.5 Novo Nordisk Type 1 Diabetes (T1D) SWOT Analysis
  9.1.6 Novo Nordisk Recent Developments
9.2 Sanofi
  9.2.1 Sanofi Type 1 Diabetes (T1D) Basic Information
  9.2.2 Sanofi Type 1 Diabetes (T1D) Product Overview
  9.2.3 Sanofi Type 1 Diabetes (T1D) Product Market Performance
  9.2.4 Sanofi Business Overview
  9.2.5 Sanofi Type 1 Diabetes (T1D) SWOT Analysis
  9.2.6 Sanofi Recent Developments
9.3 Eli Lilly
  9.3.1 Eli Lilly Type 1 Diabetes (T1D) Basic Information
  9.3.2 Eli Lilly Type 1 Diabetes (T1D) Product Overview
  9.3.3 Eli Lilly Type 1 Diabetes (T1D) Product Market Performance
  9.3.4 Eli Lilly Business Overview
  9.3.5 Eli Lilly Type 1 Diabetes (T1D) SWOT Analysis
  9.3.6 Eli Lilly Recent Developments
9.4 Merck
  9.4.1 Merck Type 1 Diabetes (T1D) Basic Information
  9.4.2 Merck Type 1 Diabetes (T1D) Product Overview
  9.4.3 Merck Type 1 Diabetes (T1D) Product Market Performance
  9.4.4 Merck Business Overview
  9.4.5 Merck Type 1 Diabetes (T1D) SWOT Analysis
  9.4.6 Merck Recent Developments
9.5 Boehringer Ingelheim
  9.5.1 Boehringer Ingelheim Type 1 Diabetes (T1D) Basic Information
  9.5.2 Boehringer Ingelheim Type 1 Diabetes (T1D) Product Overview
  9.5.3 Boehringer Ingelheim Type 1 Diabetes (T1D) Product Market Performance
  9.5.4 Boehringer Ingelheim Business Overview
  9.5.5 Boehringer Ingelheim Type 1 Diabetes (T1D) SWOT Analysis
  9.5.6 Boehringer Ingelheim Recent Developments
9.6 Samsung Bioepis
  9.6.1 Samsung Bioepis Type 1 Diabetes (T1D) Basic Information
  9.6.2 Samsung Bioepis Type 1 Diabetes (T1D) Product Overview
  9.6.3 Samsung Bioepis Type 1 Diabetes (T1D) Product Market Performance
  9.6.4 Samsung Bioepis Business Overview
  9.6.5 Samsung Bioepis Recent Developments
9.7 Biocon
  9.7.1 Biocon Type 1 Diabetes (T1D) Basic Information
  9.7.2 Biocon Type 1 Diabetes (T1D) Product Overview
  9.7.3 Biocon Type 1 Diabetes (T1D) Product Market Performance
  9.7.4 Biocon Business Overview
  9.7.5 Biocon Recent Developments
9.8 Astellas
  9.8.1 Astellas Type 1 Diabetes (T1D) Basic Information
  9.8.2 Astellas Type 1 Diabetes (T1D) Product Overview
  9.8.3 Astellas Type 1 Diabetes (T1D) Product Market Performance
  9.8.4 Astellas Business Overview
  9.8.5 Astellas Recent Developments
9.9 Janssen
  9.9.1 Janssen Type 1 Diabetes (T1D) Basic Information
  9.9.2 Janssen Type 1 Diabetes (T1D) Product Overview
  9.9.3 Janssen Type 1 Diabetes (T1D) Product Market Performance
  9.9.4 Janssen Business Overview
  9.9.5 Janssen Recent Developments
9.10 Bristol-Myers Squibb
  9.10.1 Bristol-Myers Squibb Type 1 Diabetes (T1D) Basic Information
  9.10.2 Bristol-Myers Squibb Type 1 Diabetes (T1D) Product Overview
  9.10.3 Bristol-Myers Squibb Type 1 Diabetes (T1D) Product Market Performance
  9.10.4 Bristol-Myers Squibb Business Overview
  9.10.5 Bristol-Myers Squibb Recent Developments
9.11 Lexicon
  9.11.1 Lexicon Type 1 Diabetes (T1D) Basic Information
  9.11.2 Lexicon Type 1 Diabetes (T1D) Product Overview
  9.11.3 Lexicon Type 1 Diabetes (T1D) Product Market Performance
  9.11.4 Lexicon Business Overview
  9.11.5 Lexicon Recent Developments
9.12 Sanofi
  9.12.1 Sanofi Type 1 Diabetes (T1D) Basic Information
  9.12.2 Sanofi Type 1 Diabetes (T1D) Product Overview
  9.12.3 Sanofi Type 1 Diabetes (T1D) Product Market Performance
  9.12.4 Sanofi Business Overview
  9.12.5 Sanofi Recent Developments

10 TYPE 1 DIABETES (T1D) MARKET FORECAST BY REGION

10.1 Global Type 1 Diabetes (T1D) Market Size Forecast
10.2 Global Type 1 Diabetes (T1D) Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Type 1 Diabetes (T1D) Market Size Forecast by Country
  10.2.3 Asia Pacific Type 1 Diabetes (T1D) Market Size Forecast by Region
  10.2.4 South America Type 1 Diabetes (T1D) Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Type 1 Diabetes (T1D) by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2022-2028)

11.1 Global Type 1 Diabetes (T1D) Market Forecast by Type (2022-2028)
  11.1.1 Global Forecasted Sales of Type 1 Diabetes (T1D) by Type (2022-2028)
  11.1.2 Global Type 1 Diabetes (T1D) Market Size Forecast by Type (2022-2028)
  11.1.3 Global Forecasted Price of Type 1 Diabetes (T1D) by Type (2022-2028)
11.2 Global Type 1 Diabetes (T1D) Market Forecast by Application (2022-2028)
  11.2.1 Global Type 1 Diabetes (T1D) Sales (K Units) Forecast by Application
  11.2.2 Global Type 1 Diabetes (T1D) Market Size (M USD) Forecast by Application (2022-2028)

12 CONCLUSION AND KEY FINDINGSLIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Type 1 Diabetes (T1D) Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Type 1 Diabetes (T1D) Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Type 1 Diabetes (T1D) Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Type 1 Diabetes (T1D) Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Type 1 Diabetes (T1D) Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 1 Diabetes (T1D) as of 2021)
Table 10. Global Market Type 1 Diabetes (T1D) Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Type 1 Diabetes (T1D) Sales Sites and Area Served
Table 12. Manufacturers Type 1 Diabetes (T1D) Product Type
Table 13. Global Type 1 Diabetes (T1D) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Type 1 Diabetes (T1D)
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Type 1 Diabetes (T1D) Market Challenges
Table 22. Market Restraints
Table 23. Global Type 1 Diabetes (T1D) Sales by Type (K Units)
Table 24. Global Type 1 Diabetes (T1D) Market Size by Type (M USD)
Table 25. Global Type 1 Diabetes (T1D) Sales (K Units) by Type (2017-2022)
Table 26. Global Type 1 Diabetes (T1D) Sales Market Share by Type (2017-2022)
Table 27. Global Type 1 Diabetes (T1D) Market Size (M USD) by Type (2017-2022)
Table 28. Global Type 1 Diabetes (T1D) Market Size Share by Type (2017-2022)
Table 29. Global Type 1 Diabetes (T1D) Price (USD/Unit) by Type (2017-2022)
Table 30. Global Type 1 Diabetes (T1D) Sales (K Units) by Application
Table 31. Global Type 1 Diabetes (T1D) Market Size by Application
Table 32. Global Type 1 Diabetes (T1D) Sales by Application (2017-2022) & (K Units)
Table 33. Global Type 1 Diabetes (T1D) Sales Market Share by Application (2017-2022)
Table 34. Global Type 1 Diabetes (T1D) Sales by Application (2017-2022) & (M USD)
Table 35. Global Type 1 Diabetes (T1D) Market Share by Application (2017-2022)
Table 36. Global Type 1 Diabetes (T1D) Sales Growth Rate by Application (2017-2022)
Table 37. Global Type 1 Diabetes (T1D) Sales by Region (2017-2022) & (K Units)
Table 38. Global Type 1 Diabetes (T1D) Sales Market Share by Region (2017-2022)
Table 39. North America Type 1 Diabetes (T1D) Sales by Country (2017-2022) & (K Units)
Table 40. Europe Type 1 Diabetes (T1D) Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Type 1 Diabetes (T1D) Sales by Region (2017-2022) & (K Units)
Table 42. South America Type 1 Diabetes (T1D) Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Type 1 Diabetes (T1D) Sales by Region (2017-2022) & (K Units)
Table 44. Novo Nordisk Type 1 Diabetes (T1D) Basic Information
Table 45. Novo Nordisk Type 1 Diabetes (T1D) Product Overview
Table 46. Novo Nordisk Type 1 Diabetes (T1D) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. Novo Nordisk Business Overview
Table 48. Novo Nordisk Type 1 Diabetes (T1D) SWOT Analysis
Table 49. Novo Nordisk Recent Developments
Table 50. Sanofi Type 1 Diabetes (T1D) Basic Information
Table 51. Sanofi Type 1 Diabetes (T1D) Product Overview
Table 52. Sanofi Type 1 Diabetes (T1D) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. Sanofi Business Overview
Table 54. Sanofi Type 1 Diabetes (T1D) SWOT Analysis
Table 55. Sanofi Recent Developments
Table 56. Eli Lilly Type 1 Diabetes (T1D) Basic Information
Table 57. Eli Lilly Type 1 Diabetes (T1D) Product Overview
Table 58. Eli Lilly Type 1 Diabetes (T1D) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. Eli Lilly Business Overview
Table 60. Eli Lilly Type 1 Diabetes (T1D) SWOT Analysis
Table 61. Eli Lilly Recent Developments
Table 62. Merck Type 1 Diabetes (T1D) Basic Information
Table 63. Merck Type 1 Diabetes (T1D) Product Overview
Table 64. Merck Type 1 Diabetes (T1D) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Merck Business Overview
Table 66. Merck Type 1 Diabetes (T1D) SWOT Analysis
Table 67. Merck Recent Developments
Table 68. Boehringer Ingelheim Type 1 Diabetes (T1D) Basic Information
Table 69. Boehringer Ingelheim Type 1 Diabetes (T1D) Product Overview
Table 70. Boehringer Ingelheim Type 1 Diabetes (T1D) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. Boehringer Ingelheim Business Overview
Table 72. Boehringer Ingelheim Type 1 Diabetes (T1D) SWOT Analysis
Table 73. Boehringer Ingelheim Recent Developments
Table 74. Samsung Bioepis Type 1 Diabetes (T1D) Basic Information
Table 75. Samsung Bioepis Type 1 Diabetes (T1D) Product Overview
Table 76. Samsung Bioepis Type 1 Diabetes (T1D) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Samsung Bioepis Business Overview
Table 78. Samsung Bioepis Recent Developments
Table 79. Biocon Type 1 Diabetes (T1D) Basic Information
Table 80. Biocon Type 1 Diabetes (T1D) Product Overview
Table 81. Biocon Type 1 Diabetes (T1D) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Biocon Business Overview
Table 83. Biocon Recent Developments
Table 84. Astellas Type 1 Diabetes (T1D) Basic Information
Table 85. Astellas Type 1 Diabetes (T1D) Product Overview
Table 86. Astellas Type 1 Diabetes (T1D) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Astellas Business Overview
Table 88. Astellas Recent Developments
Table 89. Janssen Type 1 Diabetes (T1D) Basic Information
Table 90. Janssen Type 1 Diabetes (T1D) Product Overview
Table 91. Janssen Type 1 Diabetes (T1D) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Janssen Business Overview
Table 93. Janssen Recent Developments
Table 94. Bristol-Myers Squibb Type 1 Diabetes (T1D) Basic Information
Table 95. Bristol-Myers Squibb Type 1 Diabetes (T1D) Product Overview
Table 96. Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Bristol-Myers Squibb Business Overview
Table 98. Bristol-Myers Squibb Recent Developments
Table 99. Lexicon Type 1 Diabetes (T1D) Basic Information
Table 100. Lexicon Type 1 Diabetes (T1D) Product Overview
Table 101. Lexicon Type 1 Diabetes (T1D) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Lexicon Business Overview
Table 103. Lexicon Recent Developments
Table 104. Sanofi Type 1 Diabetes (T1D) Basic Information
Table 105. Sanofi Type 1 Diabetes (T1D) Product Overview
Table 106. Sanofi Type 1 Diabetes (T1D) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Sanofi Business Overview
Table 108. Sanofi Recent Developments
Table 109. Global Type 1 Diabetes (T1D) Sales Forecast by Region (K Units)
Table 110. Global Type 1 Diabetes (T1D) Market Size Forecast by Region (M USD)
Table 111. North America Type 1 Diabetes (T1D) Sales Forecast by Country (2022-2028) & (K Units)
Table 112. North America Type 1 Diabetes (T1D) Market Size Forecast by Country (2022-2028) & (M USD)
Table 113. Europe Type 1 Diabetes (T1D) Sales Forecast by Country (2022-2028) & (K Units)
Table 114. Europe Type 1 Diabetes (T1D) Market Size Forecast by Country (2022-2028) & (M USD)
Table 115. Asia Pacific Type 1 Diabetes (T1D) Sales Forecast by Region (2022-2028) & (K Units)
Table 116. Asia Pacific Type 1 Diabetes (T1D) Market Size Forecast by Region (2022-2028) & (M USD)
Table 117. South America Type 1 Diabetes (T1D) Sales Forecast by Country (2022-2028) & (K Units)
Table 118. South America Type 1 Diabetes (T1D) Market Size Forecast by Country (2022-2028) & (M USD)
Table 119. Middle East and Africa Type 1 Diabetes (T1D) Consumption Forecast by Country (2022-2028) & (Units)
Table 120. Middle East and Africa Type 1 Diabetes (T1D) Market Size Forecast by Country (2022-2028) & (M USD)
Table 121. Global Type 1 Diabetes (T1D) Sales Forecast by Type (2022-2028) & (K Units)
Table 122. Global Type 1 Diabetes (T1D) Market Size Forecast by Type (2022-2028) & (M USD)
Table 123. Global Type 1 Diabetes (T1D) Price Forecast by Type (2022-2028) & (USD/Unit)
Table 124. Global Type 1 Diabetes (T1D) Sales (K Units) Forecast by Application (2022-2028)
Table 125. Global Type 1 Diabetes (T1D) Market Size Forecast by Application (2022-2028) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Type 1 Diabetes (T1D)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Type 1 Diabetes (T1D) Market Size (M USD), 2017-2028
Figure 5. Global Type 1 Diabetes (T1D) Market Size (M USD) (2017-2028)
Figure 6. Global Type 1 Diabetes (T1D) Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Type 1 Diabetes (T1D) Market Size (M USD) by Country (M USD)
Figure 11. Type 1 Diabetes (T1D) Sales Share by Manufacturers in 2020
Figure 12. Global Type 1 Diabetes (T1D) Revenue Share by Manufacturers in 2020
Figure 13. Type 1 Diabetes (T1D) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Type 1 Diabetes (T1D) Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Type 1 Diabetes (T1D) Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Type 1 Diabetes (T1D) Market Share by Type
Figure 18. Sales Market Share of Type 1 Diabetes (T1D) by Type (2017-2022)
Figure 19. Sales Market Share of Type 1 Diabetes (T1D) by Type in 2021
Figure 20. Market Size Share of Type 1 Diabetes (T1D) by Type (2017-2022)
Figure 21. Market Size Market Share of Type 1 Diabetes (T1D) by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Type 1 Diabetes (T1D) Market Share by Application
Figure 24. Global Type 1 Diabetes (T1D) Sales Market Share by Application (2017-2022)
Figure 25. Global Type 1 Diabetes (T1D) Sales Market Share by Application in 2021
Figure 26. Global Type 1 Diabetes (T1D) Market Share by Application (2017-2022)
Figure 27. Global Type 1 Diabetes (T1D) Market Share by Application in 2020
Figure 28. Global Type 1 Diabetes (T1D) Sales Growth Rate by Application (2017-2022)
Figure 29. Global Type 1 Diabetes (T1D) Sales Market Share by Region (2017-2022)
Figure 30. North America Type 1 Diabetes (T1D) Sales and Growth Rate (2017-2022) & (K Units)
Figure 31. North America Type 1 Diabetes (T1D) Sales Market Share by Country in 2020
Figure 32. U.S. Type 1 Diabetes (T1D) Sales and Growth Rate (2017-2022) & (K Units)
Figure 33. Canada Type 1 Diabetes (T1D) Sales (K Units) and Growth Rate (2017-2022)
Figure 34. Mexico Type 1 Diabetes (T1D) Sales (Units) and Growth Rate (2017-2022)
Figure 35. Europe Type 1 Diabetes (T1D) Sales and Growth Rate (2017-2022) & (K Units)
Figure 36. Europe Type 1 Diabetes (T1D) Sales Market Share by Country in 2020
Figure 37. Germany Type 1 Diabetes (T1D) Sales and Growth Rate (2017-2022) & (K Units)
Figure 38. France Type 1 Diabetes (T1D) Sales and Growth Rate (2017-2022) & (K Units)
Figure 39. U.K. Type 1 Diabetes (T1D) Sales and Growth Rate (2017-2022) & (K Units)
Figure 40. Italy Type 1 Diabetes (T1D) Sales and Growth Rate (2017-2022) & (K Units)
Figure 41. Russia Type 1 Diabetes (T1D) Sales and Growth Rate (2017-2022) & (K Units)
Figure 42. Asia Pacific Type 1 Diabetes (T1D) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Type 1 Diabetes (T1D) Sales Market Share by Region in 2020
Figure 44. China Type 1 Diabetes (T1D) Sales and Growth Rate (2017-2022) & (K Units)
Figure 45. Japan Type 1 Diabetes (T1D) Sales and Growth Rate (2017-2022) & (K Units)
Figure 46. South Korea Type 1 Diabetes (T1D) Sales and Growth Rate (2017-2022) & (K Units)
Figure 47. India Type 1 Diabetes (T1D) Sales and Growth Rate (2017-2022) & (K Units)
Figure 48. Southeast Asia Type 1 Diabetes (T1D) Sales and Growth Rate (2017-2022) & (K Units)
Figure 49. South America Type 1 Diabetes (T1D) Sales and Growth Rate (K Units)
Figure 50. South America Type 1 Diabetes (T1D) Sales Market Share by Country in 2020
Figure 51. Brazil Type 1 Diabetes (T1D) Sales and Growth Rate (2017-2022) & (K Units)
Figure 52. Argentina Type 1 Diabetes (T1D) Sales and Growth Rate (2017-2022) & (K Units)
Figure 53. Columbia Type 1 Diabetes (T1D) Sales and Growth Rate (2017-2022) & (K Units)
Figure 54. Middle East and Africa Type 1 Diabetes (T1D) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Type 1 Diabetes (T1D) Sales Market Share by Region in 2020
Figure 56. Saudi Arabia Type 1 Diabetes (T1D) Sales and Growth Rate (2017-2022) & (K Units)
Figure 57. UAE Type 1 Diabetes (T1D) Sales and Growth Rate (2017-2022) & (K Units)
Figure 58. Egypt Type 1 Diabetes (T1D) Sales and Growth Rate (2017-2022) & (K Units)
Figure 59. Nigeria Type 1 Diabetes (T1D) Sales and Growth Rate (2017-2022) & (K Units)
Figure 60. South Africa Type 1 Diabetes (T1D) Sales and Growth Rate (2017-2022) & (K Units)
Figure 61. Global Type 1 Diabetes (T1D) Sales Forecast by Volume (2017-2028) & (K Units)
Figure 62. Global Type 1 Diabetes (T1D) Market Size Forecast by Value (2017-2028) & (M USD)
Figure 63. Global Type 1 Diabetes (T1D) Sales Market Share Forecast by Type (2022-2028)
Figure 64. Global Type 1 Diabetes (T1D) Market Share Forecast by Type (2022-2028)
Figure 65. Global Type 1 Diabetes (T1D) Sales Forecast by Application (2022-2028)
Figure 66. Global Type 1 Diabetes (T1D) Market Share Forecast by Application (2022-2028)